BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:Enabling Rapid Target Selection\, Discovery and Rational Desig n of Degrading and Non-Degrading Molecular Glue to Develop Potent\, Selec tive and Safer Cures for Cancer and Beyond.\n\nMolecular glues are leadin g the charge in the race to drug the previously undruggable\, and 2025 ha s seen continued investment and partnerships driving innovation in this f ield. Returning as the industry’s only dedicated meeting\, the 4th Molecu lar Glue Drug Development Summit brings top experts from biopharma and ac ademia together for intimate networking and scientific content sharing. D esigned to address the unique challenges of molecular glues\, this meetin g will provide actionable strategies to accelerate the development of saf er\, more selective candidates toward the clinic.\n\nIf you’re looking to lead the way in the molecular glue space\, connect with the brightest mi nds\, and gain practical insights to drive programs forward - this is you r chance to solve the field’s unique challenges and shape the next wave o f innovative therapies.\n\nURLs:Brochure: \;https://go.evvnt.com/3304 519-0?pid=185 \;Tickets: \;https://go.evvnt.com/3304519-1?pid=185  \;\n\nDate and Time: Tue\, 27 Jan 2026 08:30 - Thu\, 29 Jan 2026 15: 45\n\nVenue details: Hilton Boston Logan Airport\, One Hotel Drive\, Bost on\, Massachusetts\, 02128\, United States\n\nCategory: Conferences | Sci ence\, Health &\; Medicine | Pharmaceuticals\n\nPrices:Drug Developer Pricing - Conference + 2 Workshops: USD 4197.00\,Drug Developer Pricing - Conference + 1 Workshop: USD 3598.00\,Drug Developer Pricing - Conferenc e Only: USD 2999.00\,Academic Pricing - Conference + 2 Workshops: USD 359 7.00\,Academic Pricing - Conference + 1 Workshop: USD 3098.00\,Academic P ricing - Conference Only: USD 2599.00\,Service and Solution Provider Pric ing - Conference + 2 Workshops: USD 5097.00\,Service and Solution Provide r Pricing - Conference + 1 Workshop: USD 4398.00\,Service and Solution Pr ovider Pricing - Conference Only: USD 3699.00\n\nSpeakers: Milad Rouhimog hadam\, Senior Scientist\, Abbvie\, Dong Seok Kim\, CEO\, AevisBio Inc. \ , Laura Silivian\, Senior Director\, Biogen\, Vivek Vishnudas\, Chief Tec hnology Officer\, Head of Research and Development Site\, BGPBio Inc.\, O rli Even-Or\, Director of R AND D\, Coltac Therapeutics\, Chunhai Charlie Hao\, Co-Founder\, Degrome Therapeutics\, Kyle Eastman\, Vice President\ , Head of Chemistry\, Halda Therapeutics LLC\, Anita Bellail\, Chief Exec utive Director\, HB Therapeutics Inc. \, Wu Du\, Senior Vice President - Medicinal Chemistry\, Hinova\, Ingrid Wertz\, Chief Executive Officer\, L yterian Therapeutics\, Mikolaj Slabicki\, Principal Investigator\, Massac husetts General Hospital \, Jonathan Soloman\, Director\, Novartis AG\, J ohn McGee\, Senior Vice President of Platform Technology\, Parabilis Medi cines\, Peggy Thompson\, Vice President and Head of Biology\, Plexium Inc .\, Rick Ewing\, VP\, Head of Chemistry\, Rapafusyn Pharmaceuticals \, Go utham Narla\, Chief Scientific Officer\, RAPPTA Therapeutics \, Gisele Ni shiguichi\, Targeted Protein Degradation Center Leader\, St. Jude Childre n's Research Hospital\, Stephen Hinshaw\, Senior Scientist\, Stanford Uni versity \, Eugene Chekler\, Senior Director\, Takeda Pharmaceutical\, Chr is Tame\, Chief Executive Officer\, Ternary Therapeutics\, Patrick Arsena ult\, Senior Director\, Lead Discovery\, Triana Biomedicines \, Dalia Bar syte Lovejoy\, Principal Investigator\, University of Toronto\n DTEND:20260129T154500 DTSTAMP:20260515T081459Z DTSTART:20260127T083000 LOCATION:Hilton Boston Logan Airport\, One Hotel Drive\, Boston\, Massachu setts\, 02128\, SEQUENCE:0 SUMMARY:Enabling Rapid Target Selection\, Discovery and Rational Design of Degrading and Non-Degrading Molecular Glue to Develop Potent\, Selective and Safer... UID:82292a09-99e5-4c02-a47e-5dd6cda3e647 END:VEVENT END:VCALENDAR